11:00 am – 11:30 am

Liver Disease

Learning objectives:

• To review the key studies in liver disease presented at AASLD 2023, DDW 2024 and EASL 2024
• To consider the impact of recent studies on current/future practice 

Morven Cunningham, PhD, MBBS, MRCP(UK) 

Morven Cunningham MBBS, PhD, MRCP(UK)
Staff Hepatologist, Toronto Centre for Liver Disease
Assistant Professor, Faculty of Medicine, University of Toronto

Dr. Morven Cunningham obtained an MA from the University of Cambridge, and her medical degree from Imperial College of Science, Technology and Medicine, London, UK.  She completed training in General Internal Medicine, Gastroenterology and Hepatology in London, UK and undertook a PhD at Queen Mary, University of London, studying factors influencing treatment response in chronic hepatitis C infection.  Dr. Cunningham undertook a Fellowship in Hepatology at University of Toronto before taking up her current position as Assistant Professor, University of Toronto and Staff Hepatologist at Toronto Centre for Liver Disease. She is particularly interested in education in the field of Hepatology, and in education and training of the next generation of Hepatologists.